Patents-Review.com
ClassID:

110061 ⎘

C12N2720/00034 - CPC Classification

Classification description:

dsRNA viruses; Details Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20250270661
2025-08-28

NOVEL FISH TOTIVIRUS

 #2
20250127873
2025-04-24

COMPOSITIONS AND METHODS FOR PREVENTION OF PISCINE MYOCARDITIS

 #3
20230147673
2023-05-11

RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF

 #4
20210205437
2021-07-08

Tilapia virus and uses thereof

 #5
20200254084
2020-08-13

Tilapia virus and uses thereof

 #6
20200002385
2020-01-02

Piscine myocarditis virus-like particles and methods of use thereof

 #7
20180369360
2018-12-27

Tilapia virus and uses thereof

 #8
20180215793
2018-08-02

Piscine myocarditis virus-like particles and methods of use thereof

 #9
20170360918
2017-12-21

Tilapia virus and uses thereof

 #10
20170044555
2017-02-16

Recombinant RNA particles and methods of producing proteins

 #11
20140371295
2014-12-18

Methods and compositions to protect aquatic invertebrates from disease

 #12
20140220060
2014-08-07

HIV-1 south african subtype C env proteins

 #13
20130064839
2013-03-14

Method of rapidly producing improved vaccines for animals

 #14
20130045223
2013-02-21

Methods and compositions to protect aquatic invertebrates from disease

 #15
20120269851
2012-10-25

EXPRESSION CASSETTES ENDCODING HIV-1 SOUTH AFRICAN SUBTYPE C MODIFIED PROTEINS

 #16
20120108649
2012-05-03

Methods and compositions to protect aquatic invertebrates from disease

 #17
20120107355
2012-05-03

METHOD OF RAPIDLY PRODUCING IMPROVED VACCINES FOR ANIMALS

 #18
20080089908
2008-04-17

Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2